MXCT.L

MaxCyte, Inc. [MXCT.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MXCT.L Stock Summary

Top 10 Correlated ETFs

MXCT.L

Top 10 Correlated Stocks

MXCT.L

In the News

MXCT.L Financial details

Company Rating
-
Market Cap
343.63M
Income
-35.63M
Revenue
41.29M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
143
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-15.95
Forward P/E
-
PEG
-2.84
P/S
12.44
P/B
2.27
P/C
-
P/FCF
-14.03
Quick Ratio
11.92
Current Ratio
12.87
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.3
EPS next Y
-
EPS next Q
-
EPS this Y
94.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
9.04%
Revenue last 5Y
13.81%
Revenue Q/Q
95.7%
EPS Q/Q
-
-
-
-
-
SMA20
-10.82%
SMA50
-39.23%
SMA100
-25.58%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
-14%
ROC
-0.19%
Gross Margin
88%
Oper. Margin
-123%
Profit Margin
-87%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
180.0-440.0
52W High
-51.36%
52W Low
+18.89%
RSI
48.35
Rel Volume
1.17
Avg Volume
29.47K
Volume
34.62K
Perf Week
10.88%
Perf Month
-14.4%
Perf Quarter
-29.37%
Perf Half Y
-24.91%
-
-
-
-
Beta
1.04
-
-
Volatility
6.18%, 20.75%
Prev Close
-0.47%
Price
214
Change
0.94%

Something similar

Top by Market Cap
ABEA.DE
MSFT
BRH.DE
LLY
FB2A.DE
Top Correlated ETFs
GCEX.L
G1CE.DE
SC0P.DE
GNOG.L
EALU.MI
Top Correlated Stocks
SOI.PA
BULTEN.ST
MRN.PA
JEN.DE
BAS.DE
Similar Market Cap
DCGO
ESIT.DE
1010.HK
VEL
COOK

Company Profile

Healthcare Medical - Devices
  • Volume Average 29.47K
  • Market Capitalization 343.63M
  • Employee 143
  • CEO Mr. Maher Masoud
  • Headquarters Rockville,MD,US
  • IPO Date 2016-03-29
  • Website https://maxcyte.com

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.